EntreMed (ENMD) Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
More News related to ENMD
- EntreMed's ENMD-2076 Active in Solid and Hematological Cancers
- EntreMed Inc. (ENMD) Posts Break-Even Q3 EPS, 4c Better Y/Y
- EntreMed Reports Third Quarter 2009 Financial Results
- Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference
- EntreMed (ENMD) Presents ENMD-2076 Data at ASCO
EntreMed, Inc. (Nasdaq: ENMD) has decided against seeking stockholder approval for a reverse stock split at the Annual Meeting of Stockholders to be held on June 5, 2008. In light of recent gains in the Company's stock price, management's confidence in the Company's product candidate pipeline and the Company's current cash position, the Board of Directors concluded that it is not necessary to seek stockholder approval of a reverse stock split at this time.[SM]
Related Categories
Stock SplitsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
